Induced Pluripotent Stem Cell Modeling of Gaucher's Disease: What Have We Learned?

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
osteoporosis 1 endocrinologydiseases
lysosomal storage disease 3 endocrinologydiseases

There are not enough annotations found in this document to create the proximity graph.


Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
Select Disease Character Offset Disease Term Instance
lysosomal storage disease 571 4/2017Publication date (collection): 4/2017AbstractGaucher’s disease (GD) is the most frequently inherited lysosomal storage disease , presenting both visceral and neurologic symptoms. Mutations in acid β-glucocerebrosidase disrupt the
lysosomal storage disease 1829 system.1. IntroductionGaucher’s disease (GD) is the most common autosomal, recessively inherited lysosomal storage disease (LSD). The disorder is highly variable in symptoms, severity and age of onset. The symptoms affect multiple
lysosomal storage disease 24678 Muscular Atrophy [[91]], Fanconi Anemia [[92]] and Long Q-T Syndrome [[93]], among others. Several lysosomal storage disease s have also been modeled in iPSc, including Gaucher’s disease [[94]].6. Induced Human Pluripotent Stem
osteoporosis 2154 symptoms. The systemic symptoms include hepato and splenomegaly, anemia, pancytopenia, osteopenia, osteoporosis and bone pain due to infarction or fractures. The neurological symptoms include spasticity, seizures,

You must be authorized to submit a review.